All but vanquished a quarter century ago, measles has taken root again in the U.S. Compared with prior administrations, President Donald Trump’s second term has been marred by misinformation and actions that stifle public health.
Results for “blocks trump”
Enforcement of the Trump administration's stringent new Medicaid work requirements have delayed for six months, until July 1, 2027.
The Trump administration will funnel up to $4.9 million into supporting research into ibogaine, a psychedelic that’s drawn interest as a potential treatment for PTSD and addiction.
Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump.
Federal officials say there's new funding to study the medical potential of a powerful psychedelic
Drug companies seem to be looking for workarounds to protect their U.S. sales against Trump's "most-favored nations" policy:
Incoming Democratic chairs of key congressional committees have taken a new step toward investigating most-favored nation drug pricing agreements
Incoming Democratic chairs of key committees have taken a step toward investigating MFN drug pricing agreements between drugmakers and the Trump administration.
Nebraska budgeted $8.2 million for contractors to comply with Medicaid changes under President Donald Trump’s One Big Beautiful Bill Act. Health clinics and organizations advocating for poor and working-class Nebraskans say the rollout of Medicaid work requirements has been rife with problems.
Researchers at VIB and Ghent University have uncovered how an important driver of inflammation is activated at the molecular level. Their findings, published in Science Immunology, also explain how a medicine used to treat a severe form of psoriasis blocks this inflammatory signal.
The Trump administration has removed WuXi AppTec, a key partner for the pharma industry, from its list of “Chinese military companies” operating in the U.S.
When a blood clot blocks a blood vessel, it is a very dangerous situation, as it can mean that parts of the brain, the heart muscle or the lungs no longer receive an adequate blood supply. This can result in a stroke, a heart attack or a pulmonary embolism. There are medications that can dissolve a blood clot—also known as a thrombus. However, depending on the clot's size, getting them to where they are needed can be difficult.
Novartis is largely abandoning a drug once considered a potential blockbuster after a study found it had little promise for preventing heart attacks and deaths
AI makes it easier for people to come up with new potential medicines, but may also increase the possibility of bad actors creating new bioweapons. New guidelines from Trump officials…
The model is a test of Trump's most-favored nation approach to drug pricing, though its impact is likely to be limited.
The Trump administration is facing another lawsuit over its sweeping changes to Medicaid less than a week after a federal judge ruled that implementation of work requirements would cause “irreparable…
Calley Means, a MAHA leader who just resigned from the Trump administration, says Americans "are being duped and gaslighted and lied to."
Two newly elected lawmakers with science backgrounds hope to push back against Trump administration cuts to health equity programs.
The Trump Administration has ushered in a fundamental shift in the U.S. approach to global health aid. How will the newly elected Democratic Congress weigh in?
State leaders who scrambled to win and begin spending their first-year shares of Republicans’ five-year, $50 billion fund are in the dark about how much they’ll receive in the Rural Health Transformation Program’s second year after a federal office notified states that more time is needed to make allocations.
Democrats’ retaking of Congress doesn’t change President Donald Trump’s control of the veto pen — making the new majority’s aspirations to reverse changes to Medicaid, the Affordable Care Act, and other safety net programs an uphill climb.
Democratic doctors were among the winners in the midterm elections, while the MAHA movement and President Trump's health agenda were losers.
The Trump administration will survey key components of pharmaceutical production in order to identify domestic supply chain vulnerabilities.
Democrats win Senate control, and with it the power to push back on Trump’s health care moves.
It's been just over two years since the rise of Make America Healthy Again, or MAHA. How well is the Trump administration meeting its promises?
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase by switching to lower-cost plans.
States had sued the Trump administration, arguing that a regulation would unlawfully cause very sick Americans to lose their coverage. A federal judge agreed.
A federal judge has ruled that chronically ill people on Medicaid won’t be bound by new work requirement rules that the latest Trump administration guidance requires in order to qualify for “medically frail” exemptions
A Trump administration rule will force pharmacy benefit managers to disclose fees and compensation details currently kept private.
Great news for peptide fans: The Trump administration is giving the peptide craze a regulatory boost, despite objections from FDA career scientists.
The Department of Health and Human Services will let small compounding pharmacies make six peptides that haven't been approved by the Food and Drug Administration. It may not be enough to meet demand.
Dr. Jennifer Shuford, a respected former Texas health official, had been appointed by President Trump to help steady the agency.
Director of the National Institutes of Health Dr. Jay Bhattacharya and Director of the Advanced Research Projects Agency for Health Dr. Alicia Jackson sit down with "CBS Mornings" to discuss President Trump's executive order creating a women's health division within the NIH.
A scorecard from MAHA activists suggests the Trump administration has broken most of its promises to the movement. The “burn feels especially raw,” one prominent activist said.
A Russian lab worker at an institute focused on the plague, the notorious bacterial infection tied to medieval pandemics like the Black Death, has reportedly died, which President Trump called "a big problem for Russia." Ramy Inocencio has more on what we know.
This is a MedPage Today story. Thousands of employees of federal health agencies have been let go in a chaotic and slow-rolling Trump administration purge over the holiday weekend. While the total number of dismissed employees appears to be smaller than originally expected, the changes sowed confusion as some staffers received termination notices over the weekend, while others waited for expected firings that never came. This includes members of CDC's Epidemic Intelligence Service, a 2-year fellowship program that trains the next generation of "disease detectives." One employee from an agency within HHS who asked to remain anonymous described "chaos and confusion" as leadership "tries to sort this all out." Initial reports suggested about 5,200 employees across HHS agencies -- among about 80,000 total employees -- would be let go, but on Tuesday the totals were unclear. The focus was on "probationary" employees, or those generally within the first year of their...
This is a MedPage Today story. Last Friday, St. John's Community Health, a large southern California network of federally qualified health centers serving 430,000 individuals a year, tried to withdraw funds from a $1.67 million CDC grant specifically earmarked for transgender health services. "We weren't able to access it," Jim Mangia, St. John's president and CEO, told MedPage Today, "even though there was an injunction forbidding federal departments from initiating any funding freezes or terminations based on [the president's] executive orders." And even though the money is needed for payroll and service expenses. The balance remaining in that 4-year grant, which began in June of 2022 -- $743,706 -- was stripped from their account subsequent to President Trump's Jan. 28 executive order, "Protecting Children From Chemical and Surgical Mutilation," he said. Despite that, St. John's is committed to fighting back and will find the money elsewhere, he said. It receives some $230...
This is a MedPage Today story. A new journal purports to improve the publishing process through open access and public peer review, but it was co-founded by researchers who challenged the U.S. response to COVID-19 -- including President Trump's pick to lead the NIH, Jay Bhattacharya, MD, PhD. Bhattacharya and Martin Kulldorff, PhD, have founded the Journal of the Academy of Public Health, where "good scientists can publish whatever their studies conclude," Kulldorff said in a post on X. Kulldorff reported the backdrop for launching the journal in a perspective, charging that commercial publishers have a corner on the market, with universities paying "an enormous amount of money for journals that contain articles that are both written and peer reviewed by their own scientists, which they provide to journals for free." "As a result, scientific journal publishers have huge profit margins reaching almost 40%," Kulldorff stated in the perspective. Unlike traditional publishing,...
This is a MedPage Today story. Employees at HHS and its various sub-agencies are struggling to figure out how to implement President Donald Trump's executive order requiring them to report in-person to their work sites full-time, and how the changes will affect them. An Early Executive Order The in-person work requirement was outlined in an executive order signed by President Trump on January 20, his first day in office. The two-paragraph order stated that "Heads of all departments and agencies in the executive branch of government shall, as soon as practicable, take all necessary steps to terminate remote work arrangements and require employees to return to work in-person at their respective duty stations on a full-time basis, provided that the department and agency heads shall make exemptions they deem necessary." The order was further explained in a January 27 memo to agency heads from both the Office of Personnel Management (OPM) and the Office of Management and Budget (OMB)....
This is a MedPage Today story. With Donald Trump's return to the White House and Republicans taking full control of Congress in 2025, the Affordable Care Act's Medicaid expansion is back on the chopping block. More than 3 million adults in nine states would be at immediate risk of losing their health coverage should the GOP reduce the extra federal Medicaid funding that's enabled states to widen eligibility, according to KFF, a health information nonprofit that includes KFF Health News, and the Georgetown University Center for Children and Families. That's because the states have trigger laws that would swiftly end their Medicaid expansions if federal funding falls. The states are Arizona, Arkansas, Illinois, Indiana, Montana, New Hampshire, North Carolina, Utah, and Virginia. The 2010 Affordable Care Act encouraged states to expand Medicaid programs to cover more low-income Americans who didn't get health insurance through their jobs. Forty states and the District of Columbia...































